---
layout: post
title: "基金调仓？药明康德、药明生物等多只生物医药股新年4个交易日累跌超20%"
date: 2022-01-06 11:20:56 +0800
categories: emnews
tags: 东财滚动新闻
---
> 近期持续下跌的港股生物医药股今日仍未止跌，圣诺医药跌超12%，百济神州跌超9%，药明生物跌超8%，再鼎医药、和铂医药、药明康德跌超6%。对于近期生物医药股的持续下挫，有市场分析人士称，可能主要是因为基金调仓所致。

<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02359" data-code="02359|116|5" data-code2="02359|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02359&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02359_0" data-code="K 02359|116|5" data-code2="K 02359|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02269" data-code="02269|116|5" data-code2="02269|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02269&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02269_0" data-code="K 02269|116|5" data-code2="K 02269|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>近期持续下跌的港股生物医药股今日仍未止跌，圣诺医药跌超12%，<span id="Info.116.06160"><a href="http://quote.eastmoney.com/unify/r/116.06160" class="keytip" data-code="116,06160">百济神州</a></span>跌超9%，<span id="Info.116.02269"><a href="http://quote.eastmoney.com/unify/r/116.02269" class="keytip" data-code="116,02269">药明生物</a></span>跌超8%，<span id="stock_105.ZLAB"><a href="http://quote.eastmoney.com/unify/r/105.ZLAB" class="keytip" data-code="105,ZLAB">再鼎医药</a></span><span id="quote_105.ZLAB"></span>、和铂医药、<span id="Info.116.02359"><a href="http://quote.eastmoney.com/unify/r/116.02359" class="keytip" data-code="116,02359">药明康德</a></span>跌超6%。<br /></p>
 <p>在今年的4个交易日中，<span id="Info.116.01877"><a href="http://quote.eastmoney.com/unify/r/116.01877" class="keytip" data-code="116,01877">君实生物</a></span>、康方生物、<span web="1" href="http://quote.eastmoney.com/unify/r/116.02269" class="em_stock_key_common" data-code="116,02269">药明生物</span>、荣昌生物、<span web="1" href="http://quote.eastmoney.com/unify/r/116.02359" class="em_stock_key_common" data-code="116,02359">药明康德</span>和<span id="Info.116.06127"><a href="http://quote.eastmoney.com/unify/r/116.06127" class="keytip" data-code="116,06127">昭衍新药</a></span>均累跌超20%。</p>
 <p>对于近期生物医药股的持续下挫，有市场分析人士称，可能主要是因为<span id="Info.3293"><a href="http://data.eastmoney.com/zlsj/" class="infokey">基金</a></span>调仓所致。</p><p class="em_media">（文章来源：格隆汇）</p>

<http://hk.eastmoney.com/news/1797,202201062238286685.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)